Abstract:The COVID-19 pandemic led to the rapid and worldwide development of highly effective vaccines against SARS-CoV-2. However, there is significant individual-to-individual variation in vaccine efficacy due to factors including viral variants, host age, immune status, environmental and host genetic factors. Understanding those determinants driving this variation may inform the development of more broadly protective vaccine strategies. While host genetic factors are known to impact vaccine efficacy for respiratory pathogens such as influenza and tuberculosis, the impact of host genetic variation on vaccine efficacy against COVID-19 is not well understood. To model the impact of host genetic variation on SARS-CoV-2 vaccine efficacy, while controlling for the impact of non-genetic factors, we used the Diversity Outbred (DO) mouse model. We found that DO mice immunized against SARS-CoV-2 exhibited high levels of variation in vaccine-induced neutralizing antibody responses. While the majority of the vaccinated mice were protected from virus-induced disease, similar to human populations, we observed vaccine breakthrough in a subset of mice. Importantly, we found that this variation in neutralizing antibody, virus-induced disease, and viral titer is heritable, indicating that the DO serves as a useful model system for studying the contribution of genetic variation of both vaccines and disease outcomes.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand how host genetic variation affects the immune response and vaccine efficacy of SARS - CoV - 2 vaccines. Specifically, the researchers used the Diversity Outbred (DO) mouse model with high genetic diversity to simulate the genetic diversity in the human population in order to evaluate the impact of host genetic factors on the immune response induced by SARS - CoV - 2 vaccines. In the study, DO mice were inoculated with the S2P protein subunit vaccine of SARS - CoV - 2, and a virus challenge experiment was carried out after inoculation. By observing the changes in neutralizing antibody levels, the severity of virus - induced diseases and virus loads, the impact of host genetic variation on vaccine efficacy was explored. The main objectives of the study include: 1. **Evaluate the impact of genetic diversity on the neutralizing antibody response induced by SARS - CoV - 2 vaccines**: By measuring the neutralizing antibody titers of mice with different genetic backgrounds after vaccination, the researchers hope to understand whether genetic differences will lead to significant differences in vaccine responses among individuals. 2. **Analyze the impact of genetic factors on vaccine protection**: The researchers evaluated whether genetic factors would affect the protective effect of the vaccine against SARS - CoV - 2 infection by monitoring the body weight changes and virus loads of mice after virus challenge. 3. **Explore the relationship between genetic diversity and vaccine breakthrough infections**: The study also focused on the phenomenon that some mice still had breakthrough infections even in the presence of neutralizing antibodies, aiming to reveal the role of genetic factors in this process. Through these studies, the authors hope to provide a scientific basis for the development of more widely effective vaccine strategies, especially to improve the universal applicability and effectiveness of vaccines on the basis of considering individual genetic differences.

Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse Population